Structured evidence table for Green Tea Extract Cardiometabolic Markers Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Green Tea Extract Cardiometabolic Markers Meta-Analysis | The current systematic review and meta-analysis study aimed to establish the effects of green tea supplementation on cardiovascular risk factors including lipid profile, blood pressure, glycemic control markers and CRP. | 1 | Zamani M (2023) | The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis. |
| Green Tea Extract Cardiometabolic Markers Meta-Analysis | Methods A systematic literature search of randomized clinical trials (RCTs) that investigated the effects of green tea supplementation and cardiovascular risk factors was undertaken in online databases including PubMed/Medline, Scopus, Web of Science, and Embase using a combination of green tea and cardiovascular risk factors search terms. | 1 | Zamani M (2023) | The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis. |
| Green Tea Extract Cardiometabolic Markers Meta-Analysis | Results from the random effects meta-analysis showed that GTE supplementation significantly reduced TC (WMD = -7.62; 95% CI: -10.51, -4.73; P = P = P = P = 0.008), DBP (WMD = -0.87; 95% CI: -1.45, -0.29; P = 0.003), while increasing HDL-C (WMD = 1.85; 95% CI: 0.87, 2.84; P = 0.010). | 1 | Zamani M (2023) | The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis. |
| Green Tea Extract Cardiometabolic Markers Meta-Analysis | Purpose A bulk of observational studies have revealed the protective role of green tea supplementation in cardiovascular diseases. | 1 | Zamani M (2023) | The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis. |
| Green Tea Extract Cardiometabolic Markers Meta-Analysis | Metabolic syndrome (MetS) is a multifactorial disorder characterized by central obesity, insulin resistance, dyslipidemia, and hypertension, all of which increase the risk of type 2 diabetes and cardiovascular diseases. | 4 | de la Fuente-Muñoz M (2026) | Enhanced Effects of Complex Tea Extract and the Postbiotic BPL1<sup>®</sup> HT on Ameliorating the Cardiometabolic Alterations Associated with Metabolic Syndrome in Mice. |
| Green Tea Extract Cardiometabolic Markers Meta-Analysis | This study investigates the potential complementary effects of the standardized green and black ADM ComplexTea Extract (CTE) and the heat-treated postbiotic (BPL1 ® HT) on the cardiometabolic alterations associated with MetS in a murine model. | 4 | de la Fuente-Muñoz M (2026) | Enhanced Effects of Complex Tea Extract and the Postbiotic BPL1<sup>®</sup> HT on Ameliorating the Cardiometabolic Alterations Associated with Metabolic Syndrome in Mice. |
| Green Tea Extract Cardiometabolic Markers Meta-Analysis | Co-treatment also restored PI3K/Akt signaling in liver and muscle, reduced hepatic steatosis, and normalized the expression of inflammatory and oxidative stress markers across multiple tissues. | 4 | de la Fuente-Muñoz M (2026) | Enhanced Effects of Complex Tea Extract and the Postbiotic BPL1<sup>®</sup> HT on Ameliorating the Cardiometabolic Alterations Associated with Metabolic Syndrome in Mice. |
Source documents